Daniel Gordon Kirby

Companies

• Iovance BiotherapeuticsChief Commercial Officer Feb 12, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• IBIovance Biotherapeutics IOVA154,511 shares²$2.2M at $13.92Aug 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 10, 2026Shares withheld for tax 2,436 shares at $6.40 of Iovance Biotherapeutics²
• Aug 10, 2026Exercised options 10,001 shares of Iovance Biotherapeutics²
• May 11, 2026Shares withheld for tax 2,435 shares at $3.70 of Iovance Biotherapeutics³
• May 11, 2026Exercised options 10,000 shares of Iovance Biotherapeutics³
• Feb 24, 2026Shares withheld for tax 34,165 shares at $3.78 of Iovance Biotherapeutics⁴
• Feb 24, 2026Exercised options 120,000 shares of Iovance Biotherapeutics⁴
• Feb 10, 2026Shares withheld for tax 16,450 shares at $2.60 of Iovance Biotherapeutics⁵
• Feb 10, 2026Exercised options 39,996 shares of Iovance Biotherapeutics⁵
• Jun 5, 2025Bought 30,000 shares at $1.84 of Iovance Biotherapeutics⁶